维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="HENEKA M T"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation 显示文摘	Dehmer T Heneka MT Sastre M	2004	Neurochemistry2004，88，4：	1
2	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	Dehmer T Heneka MT Sastre M	2004	J Neurochem2004，88，2：	1
3	NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PSI mice显示文摘	Heneka M T Kummer M P Stutz A	2013	Nature2013，493，7434：	1
4	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	DEHMER T HENEKA M T SASTRE M	2004	J Neurochem2004，88，2：	1
5	Noradrenergic depletion increases inflammatory responses in brain: effects on I kappa B and HSP70 expression显示文摘	Heneka M T Gavrilyuk V Landveth G E	2003	J Neurochem2003，85，：	1
6	Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	Dehmer T Heneka MT Sastre M	2004	J Neurochem2004，88，2：	1
7	Contribution of inflammatory processes to Alzheimer's disease:molecular mechanisms显示文摘	Sastre M Klockgether T Heneka M T	2006	Int J Dev Neurosci2006，24，23：	1
8	Expression and function of inducible nitric oxide synthase in neurons显示文摘	HENEKA M T Feinste in D L	2001	J Neuroimmunol2001，1，12：	1
9	Protection by pioglitazone in the MPTP model of Parkinson' s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation显示文摘	Dehmer T Heneka MT Sastre M	2004	J Neurochem2004，88，2：	1
10	Contribution of in- flammatory processes to Alzheimer s disease t molecular mecha- nisms显示文摘	Sastre M Klockgether T Heneka MT	2006	Dev Neurosci2006，24，23：	1
11	Protective action of the peroxisome proliferator-activated receptor )' agonist pioglitazone in a mouse model of Parkinson's disease显示文摘	Breidert T Callebert J Heneka M T	2002	Journal of Neurochemistry2002，82，：	1
12	Neuroinflammatory processes in Alzheimer's disease显示文摘	Heneka M T O'Banion M K Terwel D	2010	J Neural Transm2010，117，：	1
13	Contribution of inflammatory processes to Alzheimer's disease:molecular mechanisms 显示文摘	Sastre M Klockgether T Heneka MT	2006	Int J Dev Neurosci2006，24，23：	1
14	Inflammatory processes in Alzheimer~ disease 显示文摘	Heneka MT M Kerry O Dick T	2007	Journal of Neuroim- munology2007，，12：	1
15	Inflammation in Alzheimer's Disease显示文摘	HENEKA M T	2006	Clinical Neuroscience Research2006，6，5：	1
16	Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease显示文摘	LANDRETH G E HENEKA M T	2001	Neurobiol Aging2001，22，6：	1
17	Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists 显示文摘	Grommes C Landreth G E Heneka M T	2004	Lancet Oncol2004，5，7：	1
18	Pro- tection by pioglitazone in the MPTP model of Parkinson's dis- ease correlates with IkB induction and block of NF-kB and iN-OS activation显示文摘	Dehmer T Heneka M T Sastre M Dichgans J Schulz J B	2004	J Neurochem2004，88，：	1
19	Norepinephrine increase I kappa B alpha expression in astrocytes 显示文摘	Gavrilyuk V Dello Russo C Heneka M T	2002	J Biol Chem2002，277，29：	1
20	Norepinephrine increases I kappa B alpha expression in astrocytes显示文摘	GAVRILYUK V DELLO RUSSO C HENEKA M T et a1	2002	J Biol Chem2002，277，29：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示